Showing results (361-370 of 500) with videos related to

Sort By:
Pageof 50
Neuro-Oncology|October 15, 2014
Report of the Jumpstarting Brain Tumor Drug Development Coalition and FDA clinical trials neuroimaging endpoint workshop (January 30, 2014, Bethesda MD)Patrick Y Wen, Timothy F Cloughesy, Benjamin M Ellingson, et al.
Neuro-Oncology|January 8, 2023
Objective response rate targets for recurrent glioblastoma clinical trials based on the historic association between objective response rate and median overall survivalBenjamin M Ellingson, Patrick Y Wen, Susan M Chang, et al.
Neuro-Oncology|April 23, 2020
Recurrent tumor and treatment-induced effects have different MR signatures in contrast enhancing and non-enhancing lesions of high-grade gliomasJulia Cluceru, Sarah J Nelson, Qiuting Wen, et al.
Neuro-Oncology|June 19, 2008
Neurooncology clinical trial design for targeted therapies: lessons learned from the North American Brain Tumor ConsortiumSusan M Chang, Kathleen R Lamborn, John G Kuhn, et al.
Science (New York, N.Y.)|May 16, 2015
Cancer. The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancerRobert J A Bell, H Tomas Rube, Alex Kreig, et al.
BMJ Global Health|December 6, 2019
The D-score: a metric for interpreting the early development of infants and toddlers across global settingsAnn M Weber, Marta Rubio-Codina, Susan P Walker, et al.
Neuro-Oncology|February 27, 2023
Diagnosis and management of complications from the treatment of primary central nervous system tumors in adultsMichael Weller, Emilie Le Rhun, Martin Van den Bent, et al.
BMJ Open|April 29, 2024
SUPRAMAX-study: supramaximal resection versus maximal resection for glioblastoma patients: study protocol for an international multicentre prospective cohort study (ENCRAM 2201)Jasper Kees Wim Gerritsen, Jacob S Young, Susan M Chang, et al.
Sensors (Basel, Switzerland)|May 13, 2026
Development and First-in-Human Translation of Hyperpolarized [1-13C]Alpha-Ketoglutarate MR Spectroscopy in the BrainYaewon Kim, Duy Dang, James Slater, et al.
Neuro-Oncology|May 23, 2018
Corticosteroid use endpoints in neuro-oncology: Response Assessment in Neuro-Oncology Working GroupNils D Arvold, Terri S Armstrong, Katherine E Warren, et al.
Pageof 50